OSE Immunotherapeutics SA
PAR:OSE

Watchlist Manager
OSE Immunotherapeutics SA Logo
OSE Immunotherapeutics SA
PAR:OSE
Watchlist
Price: 8.89 EUR 2.42% Market Closed
Market Cap: 193.4m EUR
Have any thoughts about
OSE Immunotherapeutics SA?
Write Note

Income Statement

Earnings Waterfall
OSE Immunotherapeutics SA

Revenue
83.4m EUR
Operating Expenses
-29.5m EUR
Operating Income
53.9m EUR
Other Expenses
-7.9m EUR
Net Income
46m EUR

Income Statement
OSE Immunotherapeutics SA

Rotate your device to view
Income Statement
Currency: EUR
Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Sep-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
+900%
0
+858%
3
+733%
7
+109%
24
+266%
24
+0%
20
-19%
26
+31%
16
-39%
10
-34%
14
+30%
22
+64%
26
+18%
42
+60%
18
-56%
4
-80%
2
-38%
83
+3 647%
Gross Profit
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
9
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(3)
(5)
(5)
(15)
(17)
(15)
(19)
(20)
(20)
(21)
(27)
(28)
(29)
(37)
(49)
(43)
(53)
(37)
(32)
(26)
(30)
Selling, General & Administrative
(1)
(2)
(3)
(3)
(3)
(4)
(5)
(5)
(4)
(5)
(5)
(6)
(7)
(9)
(12)
(12)
(14)
(9)
(9)
(7)
(8)
Research & Development
(2)
(3)
(3)
(4)
(8)
(13)
(19)
(20)
(20)
(21)
(25)
(25)
(28)
(33)
(41)
(34)
(41)
(30)
(28)
(24)
(24)
Depreciation & Amortization
0
0
(0)
0
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(3)
(4)
(3)
(4)
(4)
(3)
Other Operating Expenses
0
0
1
(8)
(6)
2
4
5
5
4
4
4
6
6
6
5
6
6
8
10
4
Operating Income
(3)
N/A
(5)
-76%
(5)
-9%
(15)
-171%
(17)
-15%
(12)
+28%
(13)
-4%
5
N/A
5
-2%
(1)
N/A
(1)
0%
(12)
-747%
(19)
-52%
(23)
-24%
(26)
-12%
(16)
+38%
(11)
+34%
(18)
-70%
(29)
-57%
(23)
+19%
54
N/A
Pre-Tax Income
Interest Income Expense
(0)
(0)
(0)
0
0
0
(0)
(0)
(0)
0
(0)
(0)
(0)
(0)
0
(1)
1
0
1
(0)
(4)
Non-Reccuring Items
0
0
0
34
34
(0)
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
0
0
(0)
Total Other Income
0
(0)
(0)
0
0
0
0
0
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
Pre-Tax Income
(3)
N/A
(5)
-81%
(6)
-9%
20
N/A
18
-11%
(12)
N/A
(13)
-5%
5
N/A
5
+0%
(1)
N/A
(1)
-5%
(13)
-765%
(19)
-52%
(24)
-24%
(27)
-11%
(17)
+35%
(10)
+40%
(18)
-75%
(28)
-55%
(23)
+17%
49
N/A
Net Income
Tax Provision
(0)
0
(0)
2
3
2
2
0
1
(1)
(3)
4
3
(1)
(1)
0
0
0
0
0
(3)
Income from Continuing Operations
(3)
(5)
(6)
22
21
(10)
(11)
5
5
(3)
(5)
(8)
(17)
(25)
(28)
(17)
(10)
(18)
(28)
(23)
46
Net Income (Common)
(3)
N/A
(5)
-81%
(6)
-9%
22
N/A
21
-6%
(10)
N/A
(11)
-3%
5
N/A
5
+16%
(3)
N/A
(5)
-62%
(8)
-78%
(17)
-100%
(25)
-51%
(28)
-11%
(17)
+39%
(7)
+56%
(18)
-142%
(28)
-56%
(23)
+17%
46
N/A
EPS (Diluted)
-0.36
N/A
-0.56
-56%
-0.59
-5%
1.87
N/A
1.65
-12%
-0.71
N/A
-0.73
-3%
0.3
N/A
0.38
+27%
-0.19
N/A
-0.31
-63%
-0.55
-77%
-1.06
-93%
-1.38
-30%
-1.5
-9%
-0.93
+38%
-0.39
+58%
-0.96
-146%
-1.49
-55%
-1.18
+21%
1.82
N/A

See Also

Discover More